nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—ankylosing spondylitis—osteoporosis	0.469	1	CtDrD
Prednisolone—Exemestane—Estropipate—osteoporosis	0.111	0.432	CrCrCtD
Prednisolone—Exemestane—Conjugated Estrogens—osteoporosis	0.0844	0.328	CrCrCtD
Prednisolone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0368	0.215	CbGbCtD
Prednisolone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0323	0.126	CrCrCtD
Prednisolone—SLCO1A2—Estradiol—osteoporosis	0.0323	0.189	CbGbCtD
Prednisolone—Testosterone—Estradiol—osteoporosis	0.0295	0.115	CrCrCtD
Prednisolone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0135	0.0793	CbGbCtD
Prednisolone—CYP3A4—Estropipate—osteoporosis	0.0126	0.0738	CbGbCtD
Prednisolone—CYP3A4—Calcitriol—osteoporosis	0.0126	0.0738	CbGbCtD
Prednisolone—CYP3A4—Ergocalciferol—osteoporosis	0.0101	0.059	CbGbCtD
Prednisolone—ABCB1—Conjugated Estrogens—osteoporosis	0.00994	0.0582	CbGbCtD
Prednisolone—ABCB1—Estradiol—osteoporosis	0.00872	0.0511	CbGbCtD
Prednisolone—CYP3A4—Raloxifene—osteoporosis	0.0084	0.0492	CbGbCtD
Prednisolone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00811	0.0475	CbGbCtD
Prednisolone—CYP3A4—Cholecalciferol—osteoporosis	0.00649	0.038	CbGbCtD
Prednisolone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00595	0.0349	CbGbCtD
Prednisolone—CYP3A4—Estradiol—osteoporosis	0.00523	0.0306	CbGbCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—REN—osteoporosis	0.00129	0.103	CbGpPWpGaD
Prednisolone—NR3C2—ACE Inhibitor Pathway—ACE—osteoporosis	0.000805	0.0646	CbGpPWpGaD
Prednisolone—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00074	0.0593	CbGpPWpGaD
Prednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000456	0.0365	CbGpPWpGaD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.000356	0.0286	CbGpPWpGaD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000353	0.0283	CbGpPWpGaD
Prednisolone—SLCO1A2—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00033	0.0264	CbGpPWpGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000327	0.0262	CbGpPWpGaD
Prednisolone—Exemestane—CYP19A1—osteoporosis	0.00032	0.166	CrCbGaD
Prednisolone—Testolactone—CYP19A1—osteoporosis	0.000305	0.158	CrCbGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000259	0.0208	CbGpPWpGaD
Prednisolone—NR3C2—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.000248	0.0199	CbGpPWpGaD
Prednisolone—Fluoxymesterone—SHBG—osteoporosis	0.000209	0.109	CrCbGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000198	0.0159	CbGpPWpGaD
Prednisolone—Methyltestosterone—SHBG—osteoporosis	0.000169	0.0876	CrCbGaD
Prednisolone—Dizziness—Calcium Acetate—osteoporosis	0.000159	0.00179	CcSEcCtD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000158	0.0126	CbGpPWpGaD
Prednisolone—Erythema—Calcitriol—osteoporosis	0.000157	0.00177	CcSEcCtD
Prednisolone—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000156	0.00176	CcSEcCtD
Prednisolone—Increased appetite—Estradiol—osteoporosis	0.000156	0.00176	CcSEcCtD
Prednisolone—Conjunctivitis—Pamidronate—osteoporosis	0.000156	0.00176	CcSEcCtD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000156	0.0125	CbGpPWpGaD
Prednisolone—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000156	0.00175	CcSEcCtD
Prednisolone—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000155	0.00175	CcSEcCtD
Prednisolone—Visual disturbance—Estradiol—osteoporosis	0.000155	0.00175	CcSEcCtD
Prednisolone—Sweating increased—Conjugated Estrogens—osteoporosis	0.000154	0.00174	CcSEcCtD
Prednisolone—Ill-defined disorder—Alendronate—osteoporosis	0.000153	0.00172	CcSEcCtD
Prednisolone—Angioedema—Estropipate—osteoporosis	0.000153	0.00172	CcSEcCtD
Prednisolone—Haemoglobin—Risedronate—osteoporosis	0.000152	0.00172	CcSEcCtD
Prednisolone—Haemorrhage—Risedronate—osteoporosis	0.000152	0.00171	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Estradiol—osteoporosis	0.000152	0.00171	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000151	0.0121	CbGpPWpGaD
Prednisolone—Angioedema—Alendronate—osteoporosis	0.00015	0.0017	CcSEcCtD
Prednisolone—Vertigo—Estropipate—osteoporosis	0.00015	0.00169	CcSEcCtD
Prednisolone—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00015	0.00169	CcSEcCtD
Prednisolone—Weight increased—Zoledronate—osteoporosis	0.00015	0.00169	CcSEcCtD
Prednisolone—Ill-defined disorder—Ibandronate—osteoporosis	0.000149	0.00168	CcSEcCtD
Prednisolone—Malaise—Alendronate—osteoporosis	0.000148	0.00167	CcSEcCtD
Prednisolone—Vertigo—Alendronate—osteoporosis	0.000148	0.00167	CcSEcCtD
Prednisolone—Osteoarthritis—Estradiol—osteoporosis	0.000147	0.00166	CcSEcCtD
Prednisolone—Angioedema—Ibandronate—osteoporosis	0.000146	0.00165	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000146	0.0117	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000146	0.0117	CbGpPWpGaD
Prednisolone—Vertigo—Raloxifene—osteoporosis	0.000145	0.00164	CcSEcCtD
Prednisolone—Syncope—Raloxifene—osteoporosis	0.000145	0.00164	CcSEcCtD
Prednisolone—Haemoglobin—Pamidronate—osteoporosis	0.000145	0.00163	CcSEcCtD
Prednisolone—Malaise—Ibandronate—osteoporosis	0.000145	0.00163	CcSEcCtD
Prednisolone—Affect lability—Estradiol—osteoporosis	0.000144	0.00163	CcSEcCtD
Prednisolone—Weight increased—Conjugated Estrogens—osteoporosis	0.000144	0.00163	CcSEcCtD
Prednisolone—Haemorrhage—Pamidronate—osteoporosis	0.000144	0.00163	CcSEcCtD
Prednisolone—Vertigo—Ibandronate—osteoporosis	0.000144	0.00162	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000143	0.0115	CbGpPWpGaD
Prednisolone—Conjunctivitis—Zoledronate—osteoporosis	0.000143	0.00161	CcSEcCtD
Prednisolone—Nausea—Calcium Acetate—osteoporosis	0.000143	0.00161	CcSEcCtD
Prednisolone—Loss of consciousness—Raloxifene—osteoporosis	0.000142	0.0016	CcSEcCtD
Prednisolone—Paraesthesia—Etidronic acid—osteoporosis	0.000142	0.0016	CcSEcCtD
Prednisolone—Fluoxymesterone—ESR1—osteoporosis	0.000141	0.0733	CrCbGaD
Prednisolone—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000139	0.00157	CcSEcCtD
Prednisolone—Mood swings—Estradiol—osteoporosis	0.000139	0.00157	CcSEcCtD
Prednisolone—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.000139	0.00156	CcSEcCtD
Prednisolone—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000139	0.00156	CcSEcCtD
Prednisolone—Discomfort—Alendronate—osteoporosis	0.000138	0.00156	CcSEcCtD
Prednisolone—Hypertension—Ibandronate—osteoporosis	0.000138	0.00156	CcSEcCtD
Prednisolone—Oedema—Estropipate—osteoporosis	0.000136	0.00154	CcSEcCtD
Prednisolone—Anaphylactic shock—Estropipate—osteoporosis	0.000136	0.00154	CcSEcCtD
Prednisolone—Convulsion—Calcitriol—osteoporosis	0.000136	0.00153	CcSEcCtD
Prednisolone—Arrhythmia—Risedronate—osteoporosis	0.000136	0.00153	CcSEcCtD
Prednisolone—Hypertension—Calcitriol—osteoporosis	0.000135	0.00153	CcSEcCtD
Prednisolone—Discomfort—Ibandronate—osteoporosis	0.000135	0.00152	CcSEcCtD
Prednisolone—Dry skin—Estradiol—osteoporosis	0.000135	0.00152	CcSEcCtD
Prednisolone—Bradycardia—Zoledronate—osteoporosis	0.000134	0.00151	CcSEcCtD
Prednisolone—Discomfort—Calcitriol—osteoporosis	0.000132	0.00149	CcSEcCtD
Prednisolone—Anaphylactic shock—Ibandronate—osteoporosis	0.000131	0.00148	CcSEcCtD
Prednisolone—Shock—Raloxifene—osteoporosis	0.00013	0.00147	CcSEcCtD
Prednisolone—Feeling abnormal—Etidronic acid—osteoporosis	0.00013	0.00147	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000129	0.0103	CbGpPWpGaD
Prednisolone—Shock—Ibandronate—osteoporosis	0.000129	0.00145	CcSEcCtD
Prednisolone—Anaphylactic shock—Calcitriol—osteoporosis	0.000128	0.00144	CcSEcCtD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000128	0.0103	CbGpPWpGaD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000128	0.0102	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Raloxifene—osteoporosis	0.000128	0.00144	CcSEcCtD
Prednisolone—Abdominal distension—Estradiol—osteoporosis	0.000128	0.00144	CcSEcCtD
Prednisolone—Hydrocortisone—SHBG—osteoporosis	0.000127	0.066	CrCbGaD
Prednisolone—Hyperhidrosis—Ibandronate—osteoporosis	0.000126	0.00143	CcSEcCtD
Prednisolone—Nausea—Ergocalciferol—osteoporosis	0.000126	0.00142	CcSEcCtD
Prednisolone—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000126	0.00142	CcSEcCtD
Prednisolone—Erythema—Pamidronate—osteoporosis	0.000126	0.00142	CcSEcCtD
Prednisolone—Urticaria—Etidronic acid—osteoporosis	0.000125	0.00141	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000124	0.00997	CbGpPWpGaD
Prednisolone—Pancreatitis—Estradiol—osteoporosis	0.000124	0.0014	CcSEcCtD
Prednisolone—Methyltestosterone—CYP19A1—osteoporosis	0.000124	0.0643	CrCbGaD
Prednisolone—Angioedema—Ethinyl Estradiol—osteoporosis	0.000124	0.0014	CcSEcCtD
Prednisolone—Sweating increased—Estradiol—osteoporosis	0.000124	0.00139	CcSEcCtD
Prednisolone—Insomnia—Estropipate—osteoporosis	0.000123	0.00139	CcSEcCtD
Prednisolone—Paraesthesia—Estropipate—osteoporosis	0.000122	0.00138	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000122	0.00982	CbGpPWpGaD
Prednisolone—Visual impairment—Conjugated Estrogens—osteoporosis	0.000122	0.00138	CcSEcCtD
Prednisolone—Malaise—Ethinyl Estradiol—osteoporosis	0.000122	0.00138	CcSEcCtD
Prednisolone—Angioedema—Risedronate—osteoporosis	0.000121	0.00136	CcSEcCtD
Prednisolone—Betamethasone—CYP19A1—osteoporosis	0.00012	0.062	CrCbGaD
Prednisolone—Insomnia—Raloxifene—osteoporosis	0.000119	0.00135	CcSEcCtD
Prednisolone—Vertigo—Risedronate—osteoporosis	0.000119	0.00134	CcSEcCtD
Prednisolone—Syncope—Risedronate—osteoporosis	0.000118	0.00134	CcSEcCtD
Prednisolone—Insomnia—Ibandronate—osteoporosis	0.000118	0.00133	CcSEcCtD
Prednisolone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000118	0.00948	CbGpPWpGaD
Prednisolone—Arrhythmia—Zoledronate—osteoporosis	0.000118	0.00133	CcSEcCtD
Prednisolone—Paraesthesia—Ibandronate—osteoporosis	0.000117	0.00132	CcSEcCtD
Prednisolone—Pain—Estropipate—osteoporosis	0.000117	0.00132	CcSEcCtD
Prednisolone—Ill-defined disorder—Pamidronate—osteoporosis	0.000116	0.00131	CcSEcCtD
Prednisolone—Hypersensitivity—Etidronic acid—osteoporosis	0.000116	0.00131	CcSEcCtD
Prednisolone—Loss of consciousness—Risedronate—osteoporosis	0.000116	0.00131	CcSEcCtD
Prednisolone—Insomnia—Calcitriol—osteoporosis	0.000116	0.00131	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000116	0.00927	CbGpPWpGaD
Prednisolone—Weight increased—Estradiol—osteoporosis	0.000115	0.0013	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000115	0.00923	CbGpPWpGaD
Prednisolone—Pain—Alendronate—osteoporosis	0.000115	0.0013	CcSEcCtD
Prednisolone—Angioedema—Pamidronate—osteoporosis	0.000115	0.00129	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000115	0.00919	CbGpPWpGaD
Prednisolone—Erythema—Zoledronate—osteoporosis	0.000115	0.00129	CcSEcCtD
Prednisolone—Hypertension—Risedronate—osteoporosis	0.000114	0.00129	CcSEcCtD
Prednisolone—Discomfort—Ethinyl Estradiol—osteoporosis	0.000114	0.00129	CcSEcCtD
Prednisolone—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000113	0.00128	CcSEcCtD
Prednisolone—Malaise—Pamidronate—osteoporosis	0.000113	0.00128	CcSEcCtD
Prednisolone—Pain—Raloxifene—osteoporosis	0.000113	0.00127	CcSEcCtD
Prednisolone—Syncope—Pamidronate—osteoporosis	0.000113	0.00127	CcSEcCtD
Prednisolone—Pain—Ibandronate—osteoporosis	0.000112	0.00126	CcSEcCtD
Prednisolone—Acute coronary syndrome—Estradiol—osteoporosis	0.000111	0.00126	CcSEcCtD
Prednisolone—Myocardial infarction—Estradiol—osteoporosis	0.000111	0.00125	CcSEcCtD
Prednisolone—Neuropathy peripheral—Estradiol—osteoporosis	0.000111	0.00125	CcSEcCtD
Prednisolone—Feeling abnormal—Alendronate—osteoporosis	0.000111	0.00125	CcSEcCtD
Prednisolone—Oedema—Ethinyl Estradiol—osteoporosis	0.000111	0.00125	CcSEcCtD
Prednisolone—Erythema—Conjugated Estrogens—osteoporosis	0.00011	0.00125	CcSEcCtD
Prednisolone—Loss of consciousness—Pamidronate—osteoporosis	0.00011	0.00124	CcSEcCtD
Prednisolone—Conjunctivitis—Estradiol—osteoporosis	0.00011	0.00124	CcSEcCtD
Prednisolone—Pain—Calcitriol—osteoporosis	0.000109	0.00123	CcSEcCtD
Prednisolone—Convulsion—Pamidronate—osteoporosis	0.000109	0.00123	CcSEcCtD
Prednisolone—Hypertension—Pamidronate—osteoporosis	0.000108	0.00122	CcSEcCtD
Prednisolone—Urticaria—Estropipate—osteoporosis	0.000108	0.00122	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000108	0.00868	CbGpPWpGaD
Prednisolone—Vision blurred—Zoledronate—osteoporosis	0.000108	0.00122	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000108	0.00865	CbGpPWpGaD
Prednisolone—Feeling abnormal—Ibandronate—osteoporosis	0.000108	0.00122	CcSEcCtD
Prednisolone—Urticaria—Alendronate—osteoporosis	0.000107	0.0012	CcSEcCtD
Prednisolone—Ill-defined disorder—Zoledronate—osteoporosis	0.000106	0.0012	CcSEcCtD
Prednisolone—Shock—Risedronate—osteoporosis	0.000106	0.0012	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000106	0.00847	CbGpPWpGaD
Prednisolone—Discomfort—Pamidronate—osteoporosis	0.000106	0.00119	CcSEcCtD
Prednisolone—Angioedema—Zoledronate—osteoporosis	0.000105	0.00118	CcSEcCtD
Prednisolone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000104	0.00117	CcSEcCtD
Prednisolone—Urticaria—Ibandronate—osteoporosis	0.000104	0.00117	CcSEcCtD
Prednisolone—Progesterone—SHBG—osteoporosis	0.000104	0.0538	CrCbGaD
Prednisolone—Malaise—Zoledronate—osteoporosis	0.000103	0.00117	CcSEcCtD
Prednisolone—Vertigo—Zoledronate—osteoporosis	0.000103	0.00116	CcSEcCtD
Prednisolone—Syncope—Zoledronate—osteoporosis	0.000103	0.00116	CcSEcCtD
Prednisolone—Anaphylactic shock—Pamidronate—osteoporosis	0.000102	0.00116	CcSEcCtD
Prednisolone—Oedema—Pamidronate—osteoporosis	0.000102	0.00116	CcSEcCtD
Prednisolone—Haemoglobin—Estradiol—osteoporosis	0.000102	0.00115	CcSEcCtD
Prednisolone—Urticaria—Calcitriol—osteoporosis	0.000102	0.00115	CcSEcCtD
Prednisolone—Haemorrhage—Estradiol—osteoporosis	0.000102	0.00114	CcSEcCtD
Prednisolone—Angioedema—Conjugated Estrogens—osteoporosis	0.000101	0.00114	CcSEcCtD
Prednisolone—Shock—Pamidronate—osteoporosis	0.000101	0.00114	CcSEcCtD
Prednisolone—Loss of consciousness—Zoledronate—osteoporosis	0.000101	0.00114	CcSEcCtD
Prednisolone—Hypersensitivity—Estropipate—osteoporosis	0.0001	0.00113	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0001	0.00805	CbGpPWpGaD
Prednisolone—Tachycardia—Pamidronate—osteoporosis	0.0001	0.00113	CcSEcCtD
Prednisolone—Rash—Etidronic acid—osteoporosis	9.94e-05	0.00112	CcSEcCtD
Prednisolone—Convulsion—Zoledronate—osteoporosis	9.94e-05	0.00112	CcSEcCtD
Prednisolone—Dermatitis—Etidronic acid—osteoporosis	9.93e-05	0.00112	CcSEcCtD
Prednisolone—Vertigo—Conjugated Estrogens—osteoporosis	9.92e-05	0.00112	CcSEcCtD
Prednisolone—Hyperhidrosis—Pamidronate—osteoporosis	9.91e-05	0.00112	CcSEcCtD
Prednisolone—Syncope—Conjugated Estrogens—osteoporosis	9.9e-05	0.00112	CcSEcCtD
Prednisolone—Hypertension—Zoledronate—osteoporosis	9.9e-05	0.00112	CcSEcCtD
Prednisolone—Hypersensitivity—Alendronate—osteoporosis	9.9e-05	0.00112	CcSEcCtD
Prednisolone—Headache—Etidronic acid—osteoporosis	9.88e-05	0.00111	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	9.84e-05	0.00789	CbGpPWpGaD
Prednisolone—Testosterone—SHBG—osteoporosis	9.8e-05	0.0508	CrCbGaD
Prednisolone—Visual impairment—Estradiol—osteoporosis	9.78e-05	0.0011	CcSEcCtD
Prednisolone—Insomnia—Risedronate—osteoporosis	9.75e-05	0.0011	CcSEcCtD
Prednisolone—Loss of consciousness—Conjugated Estrogens—osteoporosis	9.7e-05	0.00109	CcSEcCtD
Prednisolone—Paraesthesia—Risedronate—osteoporosis	9.68e-05	0.00109	CcSEcCtD
Prednisolone—Discomfort—Zoledronate—osteoporosis	9.65e-05	0.00109	CcSEcCtD
Prednisolone—Hypersensitivity—Ibandronate—osteoporosis	9.64e-05	0.00109	CcSEcCtD
Prednisolone—Convulsion—Conjugated Estrogens—osteoporosis	9.57e-05	0.00108	CcSEcCtD
Prednisolone—Hypersensitivity—Calcitriol—osteoporosis	9.43e-05	0.00106	CcSEcCtD
Prednisolone—Nausea—Etidronic acid—osteoporosis	9.36e-05	0.00106	CcSEcCtD
Prednisolone—Oedema—Zoledronate—osteoporosis	9.36e-05	0.00106	CcSEcCtD
Prednisolone—Anaphylactic shock—Zoledronate—osteoporosis	9.36e-05	0.00106	CcSEcCtD
Prednisolone—Insomnia—Pamidronate—osteoporosis	9.27e-05	0.00105	CcSEcCtD
Prednisolone—Pain—Risedronate—osteoporosis	9.22e-05	0.00104	CcSEcCtD
Prednisolone—Shock—Zoledronate—osteoporosis	9.21e-05	0.00104	CcSEcCtD
Prednisolone—Paraesthesia—Pamidronate—osteoporosis	9.2e-05	0.00104	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	9.14e-05	0.00732	CbGpPWpGaD
Prednisolone—Tachycardia—Zoledronate—osteoporosis	9.13e-05	0.00103	CcSEcCtD
Prednisolone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.11e-05	0.00103	CcSEcCtD
Prednisolone—Hyperhidrosis—Zoledronate—osteoporosis	9.05e-05	0.00102	CcSEcCtD
Prednisolone—Dizziness—Estropipate—osteoporosis	9.02e-05	0.00102	CcSEcCtD
Prednisolone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.01e-05	0.00102	CcSEcCtD
Prednisolone—Oedema—Conjugated Estrogens—osteoporosis	9.01e-05	0.00102	CcSEcCtD
Prednisolone—Dizziness—Alendronate—osteoporosis	8.88e-05	0.001	CcSEcCtD
Prednisolone—Shock—Conjugated Estrogens—osteoporosis	8.87e-05	0.001	CcSEcCtD
Prednisolone—Erythema—Estradiol—osteoporosis	8.84e-05	0.000997	CcSEcCtD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	8.83e-05	0.00708	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	8.83e-05	0.00708	CbGpPWpGaD
Prednisolone—Tachycardia—Conjugated Estrogens—osteoporosis	8.8e-05	0.000992	CcSEcCtD
Prednisolone—Urticaria—Ethinyl Estradiol—osteoporosis	8.78e-05	0.00099	CcSEcCtD
Prednisolone—Pain—Pamidronate—osteoporosis	8.76e-05	0.000988	CcSEcCtD
Prednisolone—Dizziness—Raloxifene—osteoporosis	8.74e-05	0.000985	CcSEcCtD
Prednisolone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	8.71e-05	0.000983	CcSEcCtD
Prednisolone—Dizziness—Ibandronate—osteoporosis	8.65e-05	0.000975	CcSEcCtD
Prednisolone—Rash—Estropipate—osteoporosis	8.6e-05	0.00097	CcSEcCtD
Prednisolone—Dermatitis—Estropipate—osteoporosis	8.59e-05	0.000969	CcSEcCtD
Prednisolone—Urticaria—Risedronate—osteoporosis	8.56e-05	0.000966	CcSEcCtD
Prednisolone—Headache—Estropipate—osteoporosis	8.54e-05	0.000964	CcSEcCtD
Prednisolone—Rash—Alendronate—osteoporosis	8.47e-05	0.000955	CcSEcCtD
Prednisolone—Insomnia—Zoledronate—osteoporosis	8.46e-05	0.000955	CcSEcCtD
Prednisolone—Dermatitis—Alendronate—osteoporosis	8.46e-05	0.000954	CcSEcCtD
Prednisolone—Feeling abnormal—Pamidronate—osteoporosis	8.44e-05	0.000952	CcSEcCtD
Prednisolone—Headache—Alendronate—osteoporosis	8.42e-05	0.000949	CcSEcCtD
Prednisolone—Paraesthesia—Zoledronate—osteoporosis	8.4e-05	0.000948	CcSEcCtD
Prednisolone—Rash—Raloxifene—osteoporosis	8.33e-05	0.000939	CcSEcCtD
Prednisolone—Dermatitis—Raloxifene—osteoporosis	8.32e-05	0.000939	CcSEcCtD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.28e-05	0.00664	CbGpPWpGaD
Prednisolone—Headache—Raloxifene—osteoporosis	8.28e-05	0.000933	CcSEcCtD
Prednisolone—Rash—Ibandronate—osteoporosis	8.25e-05	0.00093	CcSEcCtD
Prednisolone—Dermatitis—Ibandronate—osteoporosis	8.24e-05	0.000929	CcSEcCtD
Prednisolone—Ill-defined disorder—Estradiol—osteoporosis	8.2e-05	0.000925	CcSEcCtD
Prednisolone—Headache—Ibandronate—osteoporosis	8.19e-05	0.000924	CcSEcCtD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.18e-05	0.00655	CbGpPWpGaD
Prednisolone—Insomnia—Conjugated Estrogens—osteoporosis	8.15e-05	0.000919	CcSEcCtD
Prednisolone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.14e-05	0.000919	CcSEcCtD
Prednisolone—Nausea—Estropipate—osteoporosis	8.1e-05	0.000914	CcSEcCtD
Prednisolone—Paraesthesia—Conjugated Estrogens—osteoporosis	8.09e-05	0.000913	CcSEcCtD
Prednisolone—Angioedema—Estradiol—osteoporosis	8.07e-05	0.000911	CcSEcCtD
Prednisolone—Rash—Calcitriol—osteoporosis	8.07e-05	0.00091	CcSEcCtD
Prednisolone—Dermatitis—Calcitriol—osteoporosis	8.06e-05	0.00091	CcSEcCtD
Prednisolone—Headache—Calcitriol—osteoporosis	8.02e-05	0.000905	CcSEcCtD
Prednisolone—Pain—Zoledronate—osteoporosis	8e-05	0.000903	CcSEcCtD
Prednisolone—Nausea—Alendronate—osteoporosis	7.98e-05	0.0009	CcSEcCtD
Prednisolone—Malaise—Estradiol—osteoporosis	7.97e-05	0.000899	CcSEcCtD
Prednisolone—Hypersensitivity—Risedronate—osteoporosis	7.94e-05	0.000896	CcSEcCtD
Prednisolone—Vertigo—Estradiol—osteoporosis	7.94e-05	0.000895	CcSEcCtD
Prednisolone—Syncope—Estradiol—osteoporosis	7.93e-05	0.000894	CcSEcCtD
Prednisolone—Nausea—Raloxifene—osteoporosis	7.85e-05	0.000885	CcSEcCtD
Prednisolone—Nausea—Ibandronate—osteoporosis	7.77e-05	0.000876	CcSEcCtD
Prednisolone—Loss of consciousness—Estradiol—osteoporosis	7.77e-05	0.000876	CcSEcCtD
Prednisolone—Feeling abnormal—Zoledronate—osteoporosis	7.71e-05	0.00087	CcSEcCtD
Prednisolone—Pain—Conjugated Estrogens—osteoporosis	7.71e-05	0.000869	CcSEcCtD
Prednisolone—Hypertension—Estradiol—osteoporosis	7.63e-05	0.000861	CcSEcCtD
Prednisolone—Nausea—Calcitriol—osteoporosis	7.6e-05	0.000858	CcSEcCtD
Prednisolone—Hypersensitivity—Pamidronate—osteoporosis	7.55e-05	0.000851	CcSEcCtD
Prednisolone—Urticaria—Zoledronate—osteoporosis	7.43e-05	0.000839	CcSEcCtD
Prednisolone—Discomfort—Estradiol—osteoporosis	7.43e-05	0.000838	CcSEcCtD
Prednisolone—Dizziness—Ethinyl Estradiol—osteoporosis	7.31e-05	0.000824	CcSEcCtD
Prednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	7.28e-05	0.00584	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Estradiol—osteoporosis	7.21e-05	0.000813	CcSEcCtD
Prednisolone—Oedema—Estradiol—osteoporosis	7.21e-05	0.000813	CcSEcCtD
Prednisolone—Testosterone—CYP19A1—osteoporosis	7.19e-05	0.0373	CrCbGaD
Prednisolone—Urticaria—Conjugated Estrogens—osteoporosis	7.16e-05	0.000807	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—WNT1—osteoporosis	7.13e-05	0.00572	CbGpPWpGaD
Prednisolone—Dizziness—Risedronate—osteoporosis	7.13e-05	0.000804	CcSEcCtD
Prednisolone—Shock—Estradiol—osteoporosis	7.1e-05	0.0008	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—U2AF1—osteoporosis	7.1e-05	0.00569	CbGpPWpGaD
Prednisolone—Tachycardia—Estradiol—osteoporosis	7.04e-05	0.000794	CcSEcCtD
Prednisolone—Progesterone—ESR1—osteoporosis	7e-05	0.0363	CrCbGaD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	6.98e-05	0.0056	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Estradiol—osteoporosis	6.97e-05	0.000786	CcSEcCtD
Prednisolone—Rash—Ethinyl Estradiol—osteoporosis	6.97e-05	0.000786	CcSEcCtD
Prednisolone—Dermatitis—Ethinyl Estradiol—osteoporosis	6.96e-05	0.000785	CcSEcCtD
Prednisolone—Dexamethasone—CYP19A1—osteoporosis	6.96e-05	0.0361	CrCbGaD
Prednisolone—Headache—Ethinyl Estradiol—osteoporosis	6.93e-05	0.000781	CcSEcCtD
Prednisolone—Hypersensitivity—Zoledronate—osteoporosis	6.9e-05	0.000778	CcSEcCtD
Prednisolone—Rash—Risedronate—osteoporosis	6.8e-05	0.000766	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	6.79e-05	0.00544	CbGpPWpGaD
Prednisolone—Dermatitis—Risedronate—osteoporosis	6.79e-05	0.000766	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	6.79e-05	0.00544	CbGpPWpGaD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	6.79e-05	0.00544	CbGpPWpGaD
Prednisolone—Dizziness—Pamidronate—osteoporosis	6.78e-05	0.000764	CcSEcCtD
Prednisolone—Headache—Risedronate—osteoporosis	6.75e-05	0.000762	CcSEcCtD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.72e-05	0.00538	CbGpPWpGaD
Prednisolone—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.64e-05	0.000749	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	6.63e-05	0.00531	CbGpPWpGaD
Prednisolone—Nausea—Ethinyl Estradiol—osteoporosis	6.57e-05	0.000741	CcSEcCtD
Prednisolone—Insomnia—Estradiol—osteoporosis	6.52e-05	0.000736	CcSEcCtD
Prednisolone—Paraesthesia—Estradiol—osteoporosis	6.48e-05	0.00073	CcSEcCtD
Prednisolone—Rash—Pamidronate—osteoporosis	6.46e-05	0.000729	CcSEcCtD
Prednisolone—Dermatitis—Pamidronate—osteoporosis	6.45e-05	0.000728	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—BMP2—osteoporosis	6.45e-05	0.00517	CbGpPWpGaD
Prednisolone—Headache—Pamidronate—osteoporosis	6.42e-05	0.000724	CcSEcCtD
Prednisolone—Nausea—Risedronate—osteoporosis	6.4e-05	0.000722	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.31e-05	0.00506	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	6.31e-05	0.00506	CbGpPWpGaD
Prednisolone—Dizziness—Zoledronate—osteoporosis	6.19e-05	0.000698	CcSEcCtD
Prednisolone—Pain—Estradiol—osteoporosis	6.17e-05	0.000696	CcSEcCtD
Prednisolone—Nausea—Pamidronate—osteoporosis	6.09e-05	0.000686	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.98e-05	0.0048	CbGpPWpGaD
Prednisolone—Dizziness—Conjugated Estrogens—osteoporosis	5.96e-05	0.000672	CcSEcCtD
Prednisolone—Feeling abnormal—Estradiol—osteoporosis	5.94e-05	0.00067	CcSEcCtD
Prednisolone—Rash—Zoledronate—osteoporosis	5.9e-05	0.000666	CcSEcCtD
Prednisolone—Dermatitis—Zoledronate—osteoporosis	5.9e-05	0.000665	CcSEcCtD
Prednisolone—Headache—Zoledronate—osteoporosis	5.86e-05	0.000661	CcSEcCtD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.78e-05	0.00464	CbGpPWpGaD
Prednisolone—Urticaria—Estradiol—osteoporosis	5.73e-05	0.000646	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	5.71e-05	0.00458	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.71e-05	0.00457	CbGpPWpGaD
Prednisolone—Rash—Conjugated Estrogens—osteoporosis	5.68e-05	0.000641	CcSEcCtD
Prednisolone—Dermatitis—Conjugated Estrogens—osteoporosis	5.68e-05	0.00064	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR2—osteoporosis	5.65e-05	0.00453	CbGpPWpGaD
Prednisolone—Headache—Conjugated Estrogens—osteoporosis	5.65e-05	0.000637	CcSEcCtD
Prednisolone—Nausea—Zoledronate—osteoporosis	5.56e-05	0.000627	CcSEcCtD
Prednisolone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	5.45e-05	0.00437	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	5.42e-05	0.00434	CbGpPWpGaD
Prednisolone—Nausea—Conjugated Estrogens—osteoporosis	5.35e-05	0.000604	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	5.35e-05	0.00429	CbGpPWpGaD
Prednisolone—Hypersensitivity—Estradiol—osteoporosis	5.31e-05	0.000599	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—RPL24—osteoporosis	5.27e-05	0.00423	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.98e-05	0.00399	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	4.82e-05	0.00387	CbGpPWpGaD
Prednisolone—Dizziness—Estradiol—osteoporosis	4.77e-05	0.000538	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	4.71e-05	0.00377	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.69e-05	0.00376	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.65e-05	0.00373	CbGpPWpGaD
Prednisolone—Rash—Estradiol—osteoporosis	4.55e-05	0.000513	CcSEcCtD
Prednisolone—Dermatitis—Estradiol—osteoporosis	4.54e-05	0.000512	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.53e-05	0.00364	CbGpPWpGaD
Prednisolone—Headache—Estradiol—osteoporosis	4.52e-05	0.00051	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—VDR—osteoporosis	4.48e-05	0.00359	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	4.3e-05	0.00344	CbGpPWpGaD
Prednisolone—Nausea—Estradiol—osteoporosis	4.28e-05	0.000483	CcSEcCtD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4.18e-05	0.00335	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.04e-05	0.00324	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.94e-05	0.00316	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	3.76e-05	0.00301	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.63e-05	0.00291	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	3.57e-05	0.00286	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IRS2—osteoporosis	3.53e-05	0.00283	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—LEP—osteoporosis	3.46e-05	0.00277	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR1—osteoporosis	3.43e-05	0.00275	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—AGER—osteoporosis	3.33e-05	0.00267	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	3.2e-05	0.00256	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IRS1—osteoporosis	3.09e-05	0.00247	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.08e-05	0.00247	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PSMA2—osteoporosis	3.04e-05	0.00244	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PSMA5—osteoporosis	3.04e-05	0.00244	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.04e-05	0.00244	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	3.02e-05	0.00242	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3e-05	0.0024	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	2.88e-05	0.00231	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IGF1—osteoporosis	2.86e-05	0.00229	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	2.82e-05	0.00226	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	2.81e-05	0.00225	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PKM—osteoporosis	2.81e-05	0.00225	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—FDPS—osteoporosis	2.81e-05	0.00225	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR2—osteoporosis	2.72e-05	0.00218	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PGLS—osteoporosis	2.66e-05	0.00214	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GPD2—osteoporosis	2.66e-05	0.00214	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	2.51e-05	0.00201	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	2.51e-05	0.00201	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—U2AF1—osteoporosis	2.5e-05	0.002	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.49e-05	0.002	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.46e-05	0.00197	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.46e-05	0.00197	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ATIC—osteoporosis	2.44e-05	0.00195	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PNP—osteoporosis	2.44e-05	0.00195	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—VDR—osteoporosis	2.16e-05	0.00173	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.15e-05	0.00172	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—POMC—osteoporosis	2.14e-05	0.00172	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	2.12e-05	0.0017	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—OXCT1—osteoporosis	2.07e-05	0.00166	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CA2—osteoporosis	2.07e-05	0.00166	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PKM—osteoporosis	2.02e-05	0.00162	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—FDPS—osteoporosis	2.02e-05	0.00162	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—MGLL—osteoporosis	2.02e-05	0.00162	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	2.01e-05	0.00161	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.99e-05	0.00159	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PGLS—osteoporosis	1.92e-05	0.00154	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GPD2—osteoporosis	1.92e-05	0.00154	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.91e-05	0.00153	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.9e-05	0.00153	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.87e-05	0.0015	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—RPL24—osteoporosis	1.86e-05	0.00149	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.83e-05	0.00146	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	1.78e-05	0.00143	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.76e-05	0.00141	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ATIC—osteoporosis	1.75e-05	0.00141	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PNP—osteoporosis	1.75e-05	0.00141	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—IDH2—osteoporosis	1.72e-05	0.00138	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.71e-05	0.00137	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.69e-05	0.00135	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR1—osteoporosis	1.65e-05	0.00132	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.00129	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—osteoporosis	1.6e-05	0.00128	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.58e-05	0.00127	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ACP5—osteoporosis	1.57e-05	0.00126	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.55e-05	0.00124	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CA2—osteoporosis	1.49e-05	0.0012	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—OXCT1—osteoporosis	1.49e-05	0.0012	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.48e-05	0.00119	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.48e-05	0.00119	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TPI1—osteoporosis	1.46e-05	0.00117	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—MGLL—osteoporosis	1.45e-05	0.00116	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	1.41e-05	0.00113	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.38e-05	0.00111	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—P4HB—osteoporosis	1.37e-05	0.0011	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.37e-05	0.0011	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GAPDH—osteoporosis	1.35e-05	0.00108	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—RAP1A—osteoporosis	1.31e-05	0.00105	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.31e-05	0.00105	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.3e-05	0.00105	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IL6—osteoporosis	1.29e-05	0.00104	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.29e-05	0.00103	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—osteoporosis	1.28e-05	0.00103	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—IDH2—osteoporosis	1.24e-05	0.00099	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.21e-05	0.000967	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—FDPS—osteoporosis	1.2e-05	0.000965	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PKM—osteoporosis	1.2e-05	0.000965	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP27A1—osteoporosis	1.16e-05	0.000931	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.14e-05	0.000918	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PGLS—osteoporosis	1.14e-05	0.000915	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GPD2—osteoporosis	1.14e-05	0.000915	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ACP5—osteoporosis	1.13e-05	0.000906	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.13e-05	0.000905	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.12e-05	0.000895	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PSMA2—osteoporosis	1.07e-05	0.000859	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PSMA5—osteoporosis	1.07e-05	0.000859	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ENO1—osteoporosis	1.06e-05	0.000851	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TPI1—osteoporosis	1.05e-05	0.000842	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000838	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000838	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ATIC—osteoporosis	1.04e-05	0.000837	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PNP—osteoporosis	1.04e-05	0.000837	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—P4HB—osteoporosis	9.88e-06	0.000792	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GAPDH—osteoporosis	9.69e-06	0.000777	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR2—osteoporosis	9.57e-06	0.000767	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RAP1A—osteoporosis	9.44e-06	0.000757	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—OXCT1—osteoporosis	8.87e-06	0.000711	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CA2—osteoporosis	8.87e-06	0.000711	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—MGLL—osteoporosis	8.65e-06	0.000693	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—osteoporosis	8.58e-06	0.000688	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP19A1—osteoporosis	8.48e-06	0.00068	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—POMC—osteoporosis	7.86e-06	0.00063	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ENO1—osteoporosis	7.63e-06	0.000612	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—VDR—osteoporosis	7.6e-06	0.000609	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PSMA5—osteoporosis	7.52e-06	0.000603	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PSMA2—osteoporosis	7.52e-06	0.000603	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PKM—osteoporosis	7.41e-06	0.000594	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—FDPS—osteoporosis	7.41e-06	0.000594	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—IDH2—osteoporosis	7.35e-06	0.000589	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PGLS—osteoporosis	7.03e-06	0.000563	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GPD2—osteoporosis	7.03e-06	0.000563	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ADCY5—osteoporosis	6.93e-06	0.000556	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP27A1—osteoporosis	6.91e-06	0.000554	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GPX1—osteoporosis	6.91e-06	0.000554	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.78e-06	0.000544	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.77e-06	0.000542	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ACP5—osteoporosis	6.72e-06	0.000539	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PNP—osteoporosis	6.43e-06	0.000515	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ATIC—osteoporosis	6.43e-06	0.000515	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—MTHFR—osteoporosis	6.37e-06	0.000511	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.33e-06	0.000508	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.32e-06	0.000507	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	6.27e-06	0.000503	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TPI1—osteoporosis	6.25e-06	0.000501	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP19A1—osteoporosis	6.1e-06	0.000489	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—P4HB—osteoporosis	5.88e-06	0.000471	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR1—osteoporosis	5.81e-06	0.000465	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GAPDH—osteoporosis	5.77e-06	0.000462	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RAP1A—osteoporosis	5.62e-06	0.00045	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—OXCT1—osteoporosis	5.47e-06	0.000438	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CA2—osteoporosis	5.47e-06	0.000438	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—MGLL—osteoporosis	5.33e-06	0.000427	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—POMC—osteoporosis	5.1e-06	0.000409	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ADCY5—osteoporosis	4.98e-06	0.0004	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GPX1—osteoporosis	4.97e-06	0.000398	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—MTHFR—osteoporosis	4.58e-06	0.000368	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ENO1—osteoporosis	4.54e-06	0.000364	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—IDH2—osteoporosis	4.53e-06	0.000363	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PSMA5—osteoporosis	4.48e-06	0.000359	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PSMA2—osteoporosis	4.48e-06	0.000359	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.26e-06	0.000341	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ACP5—osteoporosis	4.14e-06	0.000332	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TPI1—osteoporosis	3.85e-06	0.000309	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—POMC—osteoporosis	3.67e-06	0.000294	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP19A1—osteoporosis	3.63e-06	0.000291	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—P4HB—osteoporosis	3.62e-06	0.00029	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GAPDH—osteoporosis	3.55e-06	0.000285	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RAP1A—osteoporosis	3.46e-06	0.000278	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—osteoporosis	3.02e-06	0.000242	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ADCY5—osteoporosis	2.97e-06	0.000238	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GPX1—osteoporosis	2.96e-06	0.000237	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ENO1—osteoporosis	2.8e-06	0.000224	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PSMA2—osteoporosis	2.76e-06	0.000221	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PSMA5—osteoporosis	2.76e-06	0.000221	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—MTHFR—osteoporosis	2.73e-06	0.000219	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.24e-06	0.000179	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—POMC—osteoporosis	2.18e-06	0.000175	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ADCY5—osteoporosis	1.83e-06	0.000147	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GPX1—osteoporosis	1.82e-06	0.000146	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—MTHFR—osteoporosis	1.68e-06	0.000135	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—POMC—osteoporosis	1.34e-06	0.000108	CbGpPWpGaD
